Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome

被引：4
|
作者：
Duncavage, E. J. [1 ]
O'Brien, J. [1 ]
Vij, K. [2 ]
Miller, C. A. [3 ]
Chang, G. S. [3 ]
Shao, J. [2 ]
Jacoby, M. A. [2 ]
Heath, S. [2 ]
Janke, M. R. [2 ]
Elliott, K. [2 ]
Fulton, R. S. [3 ,4 ]
Fronick, C. [3 ]
O'Laughlin, M. [3 ]
Westervelt, P. [2 ]
Ley, T. J. [2 ,3 ,4 ]
Wilson, R. K. [3 ,4 ,5 ]
Walter, M. J. [2 ,3 ,4 ]
机构：
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
[3] Washington Univ, McDonnell Genome Inst, St Louis, MO USA
[4] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[5] Washington Univ, Dept Med, Div Genom & Bioinformat, St Louis, MO USA
来源：
LEUKEMIA | 2016年 / 30卷 / 12期
关键词：
WORLD-HEALTH-ORGANIZATION; CLONAL HEMATOPOIESIS; MUTATIONS; DIAGNOSIS; RISK; MDS;
D O I：
10.1038/leu.2016.247
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2422 / 2426
页数：6
相关论文
共 50 条
  • [1] Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome
    E J Duncavage
    J O'Brien
    K Vij
    C A Miller
    G S Chang
    J Shao
    M A Jacoby
    S Heath
    M R Janke
    K Elliott
    R S Fulton
    C Fronick
    M O'Laughlin
    P Westervelt
    T J Ley
    R K Wilson
    M J Walter
    [J]. Leukemia, 2016, 30 : 2422 - 2426
  • [2] Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome
    Petrova-Drus, Kseniya
    Hasserjian, Robert
    Pozdnyakova, Olga
    Dal Cin, Paola
    Mathew, Susan
    Margolskee, Elizabeth
    Orazi, Attilio
    Geyer, Julia T.
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 569 - 577
  • [3] Do patients with low-grade myelodysplastic syndrome (MDS) mobilise normal hemopoietic progenitors?
    Mijovic, A
    Delforge, M
    Sekhavat, M
    Czepulkowski, B
    Ghulam, MJ
    [J]. BLOOD, 2000, 96 (11) : 149A - 149A
  • [4] The current perspective of low-grade myelodysplastic syndrome in children
    Hasegawa, Daisuke
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (04) : 360 - 364
  • [5] The current perspective of low-grade myelodysplastic syndrome in children
    Daisuke Hasegawa
    [J]. International Journal of Hematology, 2016, 103 : 360 - 364
  • [6] Clinical Utility of Targeted Next Generation Sequencing (NGS) in the Evaluation of Low-Grade Lymphoid Malignancies
    Jajosky, Audrey
    Havens, Nathaniel
    Sadri, Navid
    Oduro, Kwadwo
    Moore, Erika
    Beck, Rose
    Meyerson, Howard
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1311 - 1313
  • [7] Clinical Utility of Targeted Next Generation Sequencing (NGS) in the Evaluation of Low-Grade Lymphoid Malignancies
    Jajosky, Audrey
    Havens, Nathaniel
    Sadri, Navid
    Oduro, Kwadwo
    Moore, Erika
    Beck, Rose
    Meyerson, Howard
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1311 - 1313
  • [8] Clinical Utility of Targeted Next-Generation Sequencing in the Evaluation of Low-Grade Lymphoproliferative Disorders
    Jajosky, Audrey N.
    Havens, Nathaniel P.
    Sadri, Navid
    Oduro, Kwadwo A.
    Moore, Erika M.
    Beck, Rose C.
    Meyerson, Howard J.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (03) : 433 - 444
  • [9] Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype
    Wang, Wei
    Routbort, Mark J.
    Tang, Zhenya
    Ok, Chi Young
    Patel, Keyur P.
    Daver, Naval
    Garcia-Manero, Guillermo
    Medeiros, L. Jeffrey
    Wang, Sa A.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (06) : 536 - 543
  • [10] VALUE OF EPIGENETICS IN THE DEFINITION OF RISK IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH NORMAL KARYOTYPE
    Andrade Campos, M.
    Andres Coduras, M.
    Ramos, F.
    Giraldo, P.
    [J]. HAEMATOLOGICA, 2015, 100 : 187 - 188
12345